Absorption |
Blood-Brain Barrier | BBB+ | 0.7886 |
Human Intestinal Absorption | HIA+ | 0.9809 |
Caco-2 Permeability | Caco2+ | 0.6953 |
P-glycoprotein Substrate | Non-substrate | 0.6076 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8771 |
Non-inhibitor | 0.8959 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8614 |
Distribution |
Subcellular localization | Mitochondria | 0.8607 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7770 |
CYP450 2D6 Substrate | Non-substrate | 0.9173 |
CYP450 3A4 Substrate | Non-substrate | 0.6887 |
CYP450 1A2 Inhibitor | Inhibitor | 0.5302 |
CYP450 2C9 Inhibitor | Inhibitor | 0.5354 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8354 |
CYP450 2C19 Inhibitor | Inhibitor | 0.6365 |
CYP450 3A4 Inhibitor | Inhibitor | 0.6661 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.5369 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8670 |
Non-inhibitor | 0.9607 |
AMES Toxicity | Non AMES toxic | 0.7802 |
Carcinogens | Non-carcinogens | 0.8156 |
Fish Toxicity | High FHMT | 0.9851 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9677 |
Honey Bee Toxicity | High HBT | 0.7131 |
Biodegradation | Not ready biodegradable | 0.8254 |
Acute Oral Toxicity | III | 0.6484 |
Carcinogenicity (Three-class) | Non-required | 0.5765 |